Workflow
安诺其(300067) - 2023 Q3 - 季度财报
ANOKYANOKY(SZ:300067)2023-10-23 16:00

Financial Performance - The company's revenue for Q3 2023 was ¥196,814,254.98, representing a 31.81% increase compared to the same period last year[5]. - The net profit attributable to shareholders for Q3 2023 was ¥346,550.90, a significant increase of 105.14% year-on-year[5]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥77,455.56, up 100.90% compared to the previous year[5]. - The total operating revenue for Q3 2023 was ¥590,117,512.58, a decrease of 1% compared to ¥599,706,262.00 in the same period last year[33]. - The net profit for Q3 2023 was -6,030,482.98 CNY, a significant decrease from the net profit of 43,625,463.40 CNY in Q3 2022, indicating a decline of approximately 113.8% year-over-year[34]. - The total operating costs increased to 604,010,739.54 CNY in Q3 2023 from 569,226,169.11 CNY in Q3 2022, representing an increase of about 6.1%[34]. - The operating profit for Q3 2023 was -14,867,006.41 CNY, compared to an operating profit of 46,012,855.66 CNY in Q3 2022, reflecting a decline of around 132.3%[34]. - The basic and diluted earnings per share for Q3 2023 were both -0.0087 CNY, compared to 0.0381 CNY in Q3 2022[35]. Cash Flow - The operating cash flow net amount for the year-to-date was ¥83,063,069.66, an increase of 223.85% compared to the same period last year[5]. - The net cash flow from operating activities for the year-to-date was ¥83,060,000, an increase of ¥150,130,000 compared to the previous year[15]. - Cash flow from operating activities generated a net inflow of 83,063,069.66 CNY in Q3 2023, a recovery from a net outflow of -67,068,943.49 CNY in Q3 2022[37]. - The net cash flow from investing activities was -238,758,391.21 CNY in Q3 2023, worsening from -187,719,493.91 CNY in Q3 2022[39]. - The net cash flow from financing activities was 47,626,961.48 CNY in Q3 2023, down from 86,649,800.30 CNY in Q3 2022, indicating a decrease of approximately 45%[39]. Assets and Liabilities - The total assets at the end of Q3 2023 were ¥3,104,539,442.60, reflecting a 5.40% increase from the end of the previous year[5]. - Current assets as of September 30, 2023, totaled ¥1,216,699,870.32, down from ¥1,294,048,321.53 at the beginning of the year, representing a decrease of approximately 6%[29]. - Total assets reached ¥3,104,539,442.60, up from ¥2,945,565,701.84, marking an increase of approximately 5%[31]. - Total liabilities increased to ¥751,760,510.33 from ¥587,976,802.54, which is an increase of about 28%[31]. - The company's cash and cash equivalents decreased to ¥241,480,860.93 from ¥335,397,208.58, a decline of approximately 28%[29]. - Non-current assets totaled ¥1,887,839,572.28, up from ¥1,651,517,380.31, reflecting an increase of about 14%[30]. Receivables and Payables - Accounts receivable increased by CNY 104.58 million, a growth of 58.33%, with an average collection period of four months and turnover days at 108 days[16]. - Prepayments rose by CNY 7.08 million, a significant increase of 267.42%, primarily due to advance payments to suppliers as per contractual agreements[16]. - Other receivables increased by CNY 9.69 million, up 89.18%, mainly due to a deposit of CNY 8.5 million paid to the court[16]. - Contract assets grew by CNY 5.17 million, a rise of 64.63%, attributed to new contract assets recognized by a subsidiary under the new revenue standards[16]. - Notes payable increased by CNY 50 million, a 100% rise, due to bank acceptance drafts issued to raw material suppliers[19]. - Accounts payable increased by CNY 23.21 million, a growth of 116.83%, reflecting extended payment terms from suppliers[19]. - Other payables rose by CNY 24.21 million, an increase of 52.07%, mainly due to increased engineering and equipment payables[19]. - Current portion of non-current liabilities surged by CNY 98.30 million, a dramatic increase of 979.37%, due to new long-term borrowings[19]. Research and Development - R&D expenses decreased by ¥21,660,000 compared to the previous year, as some projects were completed and new projects had not yet entered a high-investment phase[10]. - Research and development expenses decreased to 11,297,861.75 CNY in Q3 2023 from 32,957,717.26 CNY in Q3 2022, a reduction of approximately 65.8%[34].